Lakeland Industries (NASDAQ:LAKE) Now Covered by Analysts at Maxim Group

Equities researchers at Maxim Group began coverage on shares of Lakeland Industries (NASDAQ:LAKEGet Free Report) in a research note issued to investors on Wednesday, Briefing.com reports. The brokerage set a “buy” rating and a $22.00 price target on the medical instruments supplier’s stock. Maxim Group’s price target points to a potential upside of 34.89% from the company’s previous close.

Other equities analysts also recently issued reports about the stock. StockNews.com downgraded shares of Lakeland Industries from a “buy” rating to a “hold” rating in a research note on Wednesday, April 3rd. TheStreet upgraded shares of Lakeland Industries from a “c+” rating to a “b-” rating in a report on Thursday, February 1st.

Get Our Latest Research Report on Lakeland Industries

Lakeland Industries Price Performance

Shares of NASDAQ:LAKE opened at $16.31 on Wednesday. Lakeland Industries has a one year low of $10.60 and a one year high of $19.66. The stock has a fifty day moving average of $16.85 and a 200-day moving average of $16.45. The company has a market capitalization of $120.20 million, a PE ratio of 22.97 and a beta of 0.47. The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.74 and a current ratio of 5.53.

Lakeland Industries (NASDAQ:LAKEGet Free Report) last announced its quarterly earnings data on Wednesday, April 10th. The medical instruments supplier reported $0.22 EPS for the quarter, missing analysts’ consensus estimates of $0.30 by ($0.08). The company had revenue of $31.20 million for the quarter, compared to analyst estimates of $32.50 million. Lakeland Industries had a net margin of 4.33% and a return on equity of 6.63%. As a group, equities analysts anticipate that Lakeland Industries will post 1.75 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Quadrature Capital Ltd bought a new position in Lakeland Industries during the fourth quarter worth about $236,000. Equitable Trust Co. increased its holdings in shares of Lakeland Industries by 10.7% during the fourth quarter. Equitable Trust Co. now owns 27,665 shares of the medical instruments supplier’s stock worth $513,000 after buying an additional 2,680 shares in the last quarter. Barclays PLC acquired a new stake in shares of Lakeland Industries during the third quarter worth approximately $53,000. Finally, Bailard Inc. acquired a new stake in shares of Lakeland Industries during the third quarter worth approximately $225,000. Institutional investors own 71.69% of the company’s stock.

Lakeland Industries Company Profile

(Get Free Report)

Lakeland Industries, Inc manufactures and sells industrial protective clothing and accessories for the industrial and public protective clothing market worldwide. It offers firefighting and heat protective apparel to protect against fire; high-end chemical protective suits to provide protection from highly concentrated, toxic and/or lethal chemicals, and biological toxins; and limited use/disposable protective clothing, such as coveralls, laboratory coats, shirts, pants, hoods, aprons, sleeves, arm guards, caps, and smocks.

Featured Articles

Receive News & Ratings for Lakeland Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lakeland Industries and related companies with MarketBeat.com's FREE daily email newsletter.